Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1982 Aug;48(2):134–139. doi: 10.1136/hrt.48.2.134

Effect of heparin on plasma free fatty acid concentrations after acute myocardial infarction.

R A Riemersma, R Logan, D C Russell, H J Smith, J Simpson, M F Oliver
PMCID: PMC481217  PMID: 7093082

Abstract

Free fatty acid concentrations in plasma measured after in vivo heparinisation are often overestimated because of ex vivo lipolysis of variable degrees. A new method has been developed using immediate extraction of blood which obviates this and shows that the true rise in plasma free fatty acid concentration after heparin in ambulant ward patients and in patients with acute myocardial infarction is less than previously reported. The small rise in plasma free fatty acid concentration after heparin is unlikely to have adverse metabolic effects in most patients during acute myocardial infarction.

Full text

PDF
134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlström S., Christensson B. Plasma glycerol concentration in patients with myocardial ischemia and arrhythmias. Br Heart J. 1971 Nov;33(6):884–888. doi: 10.1136/hrt.33.6.884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gross H., Vaid A. K., Levine H. S., Hasson J. Anticoagulant therapy in myocardial infarction: an overview of methodology. Am J Med. 1972 Apr;52(4):421–424. doi: 10.1016/0002-9343(72)90032-0. [DOI] [PubMed] [Google Scholar]
  3. Gupta D. K., Jewitt D. E., Young R., Hartog M., Opie L. H. Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction. Lancet. 1969 Dec 6;2(7632):1209–1213. doi: 10.1016/s0140-6736(69)90749-1. [DOI] [PubMed] [Google Scholar]
  4. Henderson A. H., Most A. S., Parmley W. W., Gorlin R., Sonnenblick E. H. Depression of myocardial contractility in rats by free fatty acids during hypoxia. Circ Res. 1970 Apr;26(4):439–449. doi: 10.1161/01.res.26.4.439. [DOI] [PubMed] [Google Scholar]
  5. Ho R. J. Radiochemical assay of long-chain fatty acids using 63Ni as tracer. Anal Biochem. 1970 Jul;36(1):105–113. doi: 10.1016/0003-2697(70)90337-4. [DOI] [PubMed] [Google Scholar]
  6. Kurien V. A., Oliver M. F. A metabolic cause for arrhythmias during acute myocardial hypoxia. Lancet. 1970 Apr 18;1(7651):813–815. doi: 10.1016/s0140-6736(70)92412-8. [DOI] [PubMed] [Google Scholar]
  7. Laurell S., Tibbling G. Colorimetric micro-determination of free fatty acids in plasma. Clin Chim Acta. 1967 Apr;16(1):57–62. doi: 10.1016/0009-8981(67)90269-0. [DOI] [PubMed] [Google Scholar]
  8. Liedtke A. J., Nellis S., Neely J. R. Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine. Circ Res. 1978 Oct;43(4):652–661. doi: 10.1161/01.res.43.4.652. [DOI] [PubMed] [Google Scholar]
  9. Nelson P. G. Effect of heparin on serum free-fatty-acids, plasma catecholamines, and the incidence of arrhythmias following acute myocardial infarction. Br Med J. 1970 Sep 26;3(5725):735–737. doi: 10.1136/bmj.3.5725.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Oliver M. F., Kurien V. A., Greenwood T. W. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet. 1968 Apr 6;1(7545):710–714. doi: 10.1016/s0140-6736(68)92163-6. [DOI] [PubMed] [Google Scholar]
  11. Rogers W. J., McDaniel H. G., Moraski R. E., Rackley C. E., Russell R. O., Jr Effect of heparin-induced free fatty acid elevation on myocardial oxygen consumption in man. Am J Cardiol. 1977 Sep;40(3):365–372. doi: 10.1016/0002-9149(77)90158-8. [DOI] [PubMed] [Google Scholar]
  12. Russell D. C., Oliver M. F. Effect of antilipolytic therapy on ST segment elevation during myocardial ischaemia in man. Br Heart J. 1978 Feb;40(2):117–123. doi: 10.1136/hrt.40.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Russo J. V., Margolis S., Friesinger G. C., Ross R. S. Heparin and ventricular arrhythmias after myocardial infarction. Lancet. 1970 Dec 19;2(7686):1271–1275. doi: 10.1016/s0140-6736(70)92240-3. [DOI] [PubMed] [Google Scholar]
  14. Saliba M. J., Jr, Kuzman W. J., Marsh D. G., Lasry J. E. Effect of heparin in anticoagulant doses on the electrocardiogram and cardiac enzymes in patients with acute myocardial infarction. A clinical pilot study. Am J Cardiol. 1976 Mar 31;37(4):605–607. doi: 10.1016/0002-9149(76)90402-1. [DOI] [PubMed] [Google Scholar]
  15. Simonsen S., Kjekshus J. K. The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man. Circulation. 1978 Sep;58(3 Pt 1):484–491. doi: 10.1161/01.cir.58.3.484. [DOI] [PubMed] [Google Scholar]
  16. TROUT D. L., ESTES E. H., Jr, FRIEDBERG S. J. Titration of free fatty acids of plasma: a study of current methods and a new modification. J Lipid Res. 1960 Apr;1:199–202. [PubMed] [Google Scholar]
  17. Tan M. H. The lipoprotein lipase system: new understandings. Can Med Assoc J. 1978 Mar 18;118(6):675–680. [PMC free article] [PubMed] [Google Scholar]
  18. Warlow C., Terry G., Kenmure A. C., Beattie A. G., Ogston D., Douglas A. S. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet. 1973 Oct 27;2(7835):934–936. doi: 10.1016/s0140-6736(73)92597-x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES